A method for the determination of the percentage of CD4 T cells and CD4/CD8 ratio
Award amount
$149,972Program and phase
SBIR · Phase IAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ALLIED INNOVATIVE SYSTEMS
- Proposal award date
- 2015-06-15
- Contract end date
- 2016-05-31
- UEI
- SFFKG8THUH55
- Solicitation number
- PA14-071
- Topic code
- NIAID
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Highly sensitive immunoassay for determination of biomarkers for neurodegenerative diseases
- Highly sensitive immunoassay for determination of biomarkers for neurodegenerative diseases
- A multiplex assay for early detection of Cutaneous T-Cell Lymphoma
- Ultra sensitive method for HIV p antigen detection
- A new hemagglutination method for blood grouping
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients
Research funding history
21 SBIR/STTR records share this UEI (2000–2023). Reported award amounts total $10,630,804. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services